Skip to main content

Skopos Labs, Inc.

SEC CIK
0001795705
Latest filing
Apr 29, 2026

The latest 13F from Skopos Labs, Inc. covers Q1 2026 (filed Apr 29, 2026): 1,827 long positions worth $3.20B. The top 10 holdings make up 23.2% of the portfolio, and the largest is NVIDIA Corp (NVDA) at 4.5%. Livermore has 12 filings on Form 13F from this institution, going back to Q4 2023.

What changed in Q1 2026

Share counts compared with Q4 2025: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
543
Est. +$268.2M
Added
1055
Est. +$934.8M
Reduced
218
Est. −$46.4M
Sold out
214
Est. −$71.1M

Top 5 holdings

Share of this quarter's portfolio value

  1. NVDANVIDIA Corp
    4.5%$143.3MHistory
  2. AAPLApple Inc.
    4.2%$135.7MHistory
  3. iShares Core U.S. Aggregate Bond ETF464287226
    3.1%$98.3M
  4. MSFTMicrosoft Corp
    2.8%$88.3MHistory
  5. AMZNAmazon Com Inc
    2.1%$67.8MHistory

Biggest buys

New and added positions, by estimated amount bought

  1. NVDANVIDIA Corp
    +$52.4MAddedHistory
  2. AAPLApple Inc.
    +$47.0MAddedHistory
  3. iShares Core U.S. Aggregate Bond ETF464287226
    +$32.4MAdded
  4. MSFTMicrosoft Corp
    +$20.9MAddedHistory
  5. Vanguard Total International Bond ETF92203J407
    +$20.8MAdded

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. Vanguard Morningstar Value ETF922908744
    +0.32 pp0.7% → 1.0%
  2. Vanguard Total International Bond ETF92203J407
    +0.29 pp1.1% → 1.4%
  3. Vanguard Star FDS921909768
    +0.22 pp0.6% → 0.8%
  4. COSTCostco Wholesale Corp
    +0.20 pp0.4% → 0.6%History
  5. XOMExxonMobil Holdings Corp
    +0.20 pp0.7% → 0.9%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. AZNAstraZeneca PLC
    −$6.70MReducedConverted for a 1-for-2 splitHistory
  2. Schwab Strategic Tr808524862
    −$3.22MReduced
  3. Litman Gregory FDS Tr53700T744
    −$3.04MSold out
  4. PLSEPulse Biosciences, Inc.
    −$2.59MReducedHistory
  5. HDBHDFC Bank Ltd
    −$1.99MReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. Schwab Strategic Tr808524862
    −0.35 pp0.8% → 0.4%
  2. AZNAstraZeneca PLC
    −0.35 pp0.5% → 0.2%History
  3. HDBHDFC Bank Ltd
    −0.24 pp0.3% → 0.1%History
  4. SHOPShopify Inc.
    −0.19 pp0.3% → 0.1%History
  5. Litman Gregory FDS Tr53700T744
    −0.14 pp0.1% → 0.0%

Metrics

13F metrics for Q1 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$3.20B
+$1.03B (+47.6%) vs. prior quarter
Positions
1,827
+329 vs. prior quarter
Top 10 concentration
23.2%
Top 10 as share of value
Turnover
4.4%
Q1 2026, one quarter
Average holding period
6.9 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q4 2023), so positions held before then are understated.

13F filings by quarter

10 quarters, going back to Q4 2023. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $3.20B (Q1 2026)

Q4 2023: $209.8MQ1 2024: $232.5MQ2 2024: $232.5MQ3 2024: $303.9MQ4 2024: $335.6MQ1 2025: $463.1MQ2 2025: $761.8MQ3 2025: $740.4MQ4 2025: $2.17BQ1 2026: $3.20B
Q4 2023Q1 2026
13F filings of Skopos Labs, Inc. by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q1 2026Apr 29, 20261,827$3.20BNVDAAAPLiShares Core U.S. Aggregate Bond ETFvs. Q4 2025SEC
Q4 2025Feb 12, 20261,498$2.17BNVDAAAPLMSFTvs. Q3 2025SEC
Q3 2025Nov 14, 2025Amended660$740.4MNVDAMSFTAAPLvs. Q2 2025SEC
Q2 2025Aug 14, 2025Amended3,304$761.8MAAPLNVDAMSFTvs. Q1 2025SEC
Q1 2025May 13, 20252,769$463.1MAAPLMSFTNVDAvs. Q4 2024SEC
Q4 2024Jan 15, 20251,942$335.6MAAPLMSFTNVDAvs. Q3 2024SEC
Q3 2024Nov 13, 20241,039$303.9MAAPLMSFTNVDAvs. Q2 2024SEC
Q2 2024Aug 12, 2024229$232.5MMSFTAAPLNVDAvs. Q1 2024SEC
Q1 2024May 7, 2024229$232.5MMSFTAAPLNVDAvs. Q4 2023SEC
Q4 2023Feb 9, 2024219$209.8MAAPLMSFTAMZN–SEC